Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension
Key result
Review evaluates nifedipine and other calcium channel blockers for managing CAD and hypertension.
Why the study?
Do nifedipine and other calcium channel blockers improve outcomes in patients with coronary artery disease and hypertension?
Population
Patients with coronary artery disease and hypertension
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports cautious CCB interpretation in CAD and hypertension; leaves open optimal selection and safety via rigorous trials.
Structured PICO
Do nifedipine and other calcium channel blockers improve outcomes in patients with coronary artery disease and hypertension?
P
Population
Patients with coronary artery disease and hypertension
I
Intervention
Nifedipine and other calcium channel blockers
This paper provides a critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
Cite This Study
Tijssen et al. (1996) studied this question. Nifedipine and other calcium channel blockers were critically appraised regarding their role and efficacy in the management of coronary artery disease and hypertension.